Skip to main content
Top
Published in: BMC Public Health 1/2011

Open Access 01-12-2011 | Research article

Who pays and who benefits? How different models of shared responsibilities between formal and informal carers influence projections of costs of dementia management

Authors: Victor Vickland, Joel Werner, Thomas Morris, Geoff McDonnell, Brian Draper, Lee-Fay Low, Henry Brodaty

Published in: BMC Public Health | Issue 1/2011

Login to get access

Abstract

Background

The few studies that have attempted to estimate the future cost of caring for people with dementia in Australia are typically based on total prevalence and the cost per patient over the average duration of illness. However, costs associated with dementia care also vary according to the length of the disease, severity of symptoms and type of care provided. This study aimed to determine more accurately the future costs of dementia management by taking these factors into consideration.

Methods

The current study estimated the prevalence of dementia in Australia (2010-2040). Data from a variety of sources was recalculated to distribute this prevalence according to the location (home/institution), care requirements (informal/formal), and dementia severity. The cost of care was attributed to redistributed prevalences and used in prediction of future costs of dementia.

Results

Our computer modeling indicates that the ratio between the prevalence of people with mild/moderate/severe dementia will change over the three decades from 2010 to 2040 from 50/30/20 to 44/32/24.
Taking into account the severity of symptoms, location of care and cost of care per hour, the current study estimates that the informal cost of care in 2010 is AU$3.2 billion and formal care at AU$5.0 billion per annum. By 2040 informal care is estimated to cost AU$11.6 billion and formal care $AU16.7 billion per annum. Interventions to slow disease progression will result in relative savings of 5% (AU$1.5 billion) per annum and interventions to delay disease onset will result in relative savings of 14% (AU$4 billion) of the cost per annum.
With no intervention, the projected combined annual cost of formal and informal care for a person with dementia in 2040 will be around AU$38,000 (in 2010 dollars). An intervention to delay progression by 2 years will see this reduced to AU$35,000.

Conclusions

These findings highlight the need to account for more than total prevalence when estimating the costs of dementia care. While the absolute values of cost of care estimates are subject to the validity and reliability of currently available data, dynamic systems modeling allows for future trends to be estimated.
Appendix
Available only for authorised users
Literature
1.
go back to reference Ageing and aged care in Australia. 2008, Department of Health and Ageing Ageing and aged care in Australia. 2008, Department of Health and Ageing
2.
go back to reference Vickland V, McDonnell G, Werner J, Draper B, Low LF, Brodaty H: A computer model of dementia prevalence in Australia: foreseeing outcomes of delaying dementia onset, slowing disease progression, and eradicating dementia types. Dement Geriatr Cogn Disord. 2010, 29 (2): 123-30. 10.1159/000272436.CrossRefPubMed Vickland V, McDonnell G, Werner J, Draper B, Low LF, Brodaty H: A computer model of dementia prevalence in Australia: foreseeing outcomes of delaying dementia onset, slowing disease progression, and eradicating dementia types. Dement Geriatr Cogn Disord. 2010, 29 (2): 123-30. 10.1159/000272436.CrossRefPubMed
3.
go back to reference Nepal B, Ranmuthugala G, Brown L, Budge M: Modelling costs of dementia in Australia: evidence, gaps, and needs. Aust Health Rev. 2008, 32 (3): 479-87. 10.1071/AH080479.CrossRefPubMed Nepal B, Ranmuthugala G, Brown L, Budge M: Modelling costs of dementia in Australia: evidence, gaps, and needs. Aust Health Rev. 2008, 32 (3): 479-87. 10.1071/AH080479.CrossRefPubMed
4.
go back to reference Quentin W, Riedel-Heller SG, Luppa M, Rudolph A, Konig HH: Cost-of-illness studies of dementia: a systematic review focusing on stage dependency of costs. Acta Psychiatr Scand. 2010, 121 (4): 243-59. 10.1111/j.1600-0447.2009.01461.x.CrossRefPubMed Quentin W, Riedel-Heller SG, Luppa M, Rudolph A, Konig HH: Cost-of-illness studies of dementia: a systematic review focusing on stage dependency of costs. Acta Psychiatr Scand. 2010, 121 (4): 243-59. 10.1111/j.1600-0447.2009.01461.x.CrossRefPubMed
5.
go back to reference Wolstenholme J, Fenn P, Gray A, Keene J, Jacoby R, Hope T: Estimating the relationship between disease progression and cost of care in dementia. Br J Psychiatry. 2002, 181: 36-42. 10.1192/bjp.181.1.36.CrossRefPubMed Wolstenholme J, Fenn P, Gray A, Keene J, Jacoby R, Hope T: Estimating the relationship between disease progression and cost of care in dementia. Br J Psychiatry. 2002, 181: 36-42. 10.1192/bjp.181.1.36.CrossRefPubMed
6.
go back to reference Changing the trajectory of Alzheimer's disease: A national imperative. 2010, Alzheimer's Association Changing the trajectory of Alzheimer's disease: A national imperative. 2010, Alzheimer's Association
7.
go back to reference Making Choices - Future Dementia Care: Projections, Problems & Preferences. 2009, Report to Alzheimer's Australia: Access Economics Making Choices - Future Dementia Care: Projections, Problems & Preferences. 2009, Report to Alzheimer's Australia: Access Economics
8.
go back to reference Brookmeyer R, Gray S, Kawas C: Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset. Am J Public Health. 1998, 88 (9): 1337-42. 10.2105/AJPH.88.9.1337.CrossRefPubMedPubMedCentral Brookmeyer R, Gray S, Kawas C: Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset. Am J Public Health. 1998, 88 (9): 1337-42. 10.2105/AJPH.88.9.1337.CrossRefPubMedPubMedCentral
9.
go back to reference The Dementia Epidemic: Economic Impact and Positive Solutions for Australia. 2003, Report to Alzheimer's Australia: Access Economics The Dementia Epidemic: Economic Impact and Positive Solutions for Australia. 2003, Report to Alzheimer's Australia: Access Economics
10.
go back to reference Andrews G, Health WHOCCfCi M.: Tolkien II: a needs-based, costed, stepped-care model for Mental Health Services: recommendations, executive summaries, clinical pathways, treatment flowcharts, costing structures. Gavin Andrews and the Tolkein II team. 2006, Sydney, N.S.W: World Health Organization, Collaborating Centre for Classification in Mental Health Andrews G, Health WHOCCfCi M.: Tolkien II: a needs-based, costed, stepped-care model for Mental Health Services: recommendations, executive summaries, clinical pathways, treatment flowcharts, costing structures. Gavin Andrews and the Tolkein II team. 2006, Sydney, N.S.W: World Health Organization, Collaborating Centre for Classification in Mental Health
11.
go back to reference Dementia in Australia: National data analysis and development. 2007, Canberra: Australian Institute of Health and Welfare (AIHW), Contract No.: AIHW cat. no. AGE 53. Dementia in Australia: National data analysis and development. 2007, Canberra: Australian Institute of Health and Welfare (AIHW), Contract No.: AIHW cat. no. AGE 53.
12.
go back to reference Delaying the onset of Alzheimer's Disease: Projections and issues. 2004, Report to Alzheimer's Australia: Access Economics Delaying the onset of Alzheimer's Disease: Projections and issues. 2004, Report to Alzheimer's Australia: Access Economics
13.
go back to reference Peters R: The prevention of dementia. Int J Geriat Psychiatry. 2009, 24 (5): 452-458. 10.1002/gps.2153.CrossRef Peters R: The prevention of dementia. Int J Geriat Psychiatry. 2009, 24 (5): 452-458. 10.1002/gps.2153.CrossRef
14.
go back to reference Vickland V, McDonnell G, Werner J, Draper B, Low LF, Brodaty H: In silico modeling systems: Learning about the prevalence and dynamics of dementia through virtual experimentation. Alzheimer's Dement. 2011, 7: e77-e83. 10.1016/j.jalz.2010.11.011.CrossRef Vickland V, McDonnell G, Werner J, Draper B, Low LF, Brodaty H: In silico modeling systems: Learning about the prevalence and dynamics of dementia through virtual experimentation. Alzheimer's Dement. 2011, 7: e77-e83. 10.1016/j.jalz.2010.11.011.CrossRef
15.
go back to reference Schedule of pharmaceutical benefits, 1 July 2011 - 31 July 2011. 2011, Australian Government Department of Health and Ageing Schedule of pharmaceutical benefits, 1 July 2011 - 31 July 2011. 2011, Australian Government Department of Health and Ageing
16.
go back to reference Algase DL, Beck C, Kolanowski A, Whall A, Berent S, Richards K, et al: Need-driven dementia-compromised behavior: An alternative view of disruptive behavior. American Journal of Alzheimer's Disease and Other Dementias. 1996, 11 (6): 10-9. 10.1177/153331759601100603. November/December 1996CrossRef Algase DL, Beck C, Kolanowski A, Whall A, Berent S, Richards K, et al: Need-driven dementia-compromised behavior: An alternative view of disruptive behavior. American Journal of Alzheimer's Disease and Other Dementias. 1996, 11 (6): 10-9. 10.1177/153331759601100603. November/December 1996CrossRef
17.
go back to reference Chronic Diseases and Associated Risk Factors in Australia. 2006, The Australian Institute of Health and Welfare Chronic Diseases and Associated Risk Factors in Australia. 2006, The Australian Institute of Health and Welfare
18.
go back to reference Babel B, Bomsdorf E, Schmidt R: Future life expectancy in Australia, Europe, Japan and North America. Journal of Population Research. 2007, 24 (1): 119-31. 10.1007/BF03031881.CrossRef Babel B, Bomsdorf E, Schmidt R: Future life expectancy in Australia, Europe, Japan and North America. Journal of Population Research. 2007, 24 (1): 119-31. 10.1007/BF03031881.CrossRef
19.
go back to reference Dubois B, Feldman H, Jacova C, Cummings J, DeKosky S, Barberger-Gateau P, et al: Revising the definition of Alzheimer's disease: a new lexicon. The Lancet. 2010, 9 (11): 1118-27. 10.1016/S1474-4422(10)70223-4. NeurologyCrossRefPubMed Dubois B, Feldman H, Jacova C, Cummings J, DeKosky S, Barberger-Gateau P, et al: Revising the definition of Alzheimer's disease: a new lexicon. The Lancet. 2010, 9 (11): 1118-27. 10.1016/S1474-4422(10)70223-4. NeurologyCrossRefPubMed
Metadata
Title
Who pays and who benefits? How different models of shared responsibilities between formal and informal carers influence projections of costs of dementia management
Authors
Victor Vickland
Joel Werner
Thomas Morris
Geoff McDonnell
Brian Draper
Lee-Fay Low
Henry Brodaty
Publication date
01-12-2011
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2011
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/1471-2458-11-793

Other articles of this Issue 1/2011

BMC Public Health 1/2011 Go to the issue